Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-21
1994-05-24
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 544115, 544238, A61K 3150
Patent
active
053148835
ABSTRACT:
A compound of the formula: ##STR1## or its pharmaceutically acceptable salt and pharmaceutical compositions containing these compounds as effective ingredients. These compounds have strong antithrombotic activity, cardiotonic activity, vasodilator activity and anti-SRS-A activity, and are useful as prophylactic or therapeutic agents for various thrombotic afflictions, congestive heart failure, hypertension, asthma, immediate-type allergy diseases and the like.
REFERENCES:
patent: 4097592 (1978-06-01), Hofer et al.
patent: 4978665 (1990-12-01), Tanikawa et al.
patent: 5011839 (1991-04-01), Tanikawa et al.
patent: 5034391 (1991-07-01), Blaschke et al.
patent: 5098900 (1992-03-01), Mutsukado et al.
Burger, ed. "Medicinal Chemistry" 2d Edt. Interscience, N.Y. (1960) p. 42.
Ferlux, Chem Abstr vol. 77 entry 68522v.
Craloyan et al Chem. Abstr vol. 75 Entry 140785b (1971).
Matsumoto Takashi
Saito Akira
Sakoda Ryozo
Shikada Ken-ichi
Tanikawa Keizo
Daus Donald G.
Nissan Chemical Industries Ltd.
LandOfFree
5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1972812